SCHEMBL5285786

SCHEMBL5285786

CCC(O)OS(=O)(=O)OC.[CaH2]

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trimethylammonium SCHEMBL28046702 0.90 TSHR (0.36) TSHR
SCHEMBL5155580 0.85 TSHR (0.48) TSHR
SCHEMBL7266590 0.77 TSHR (0.40) TSHR
SCHEMBL701817 0.77 TSHR (0.40) TSHR
Ammonia Solution, Strong SCHEMBL28010226 0.76 TSHR (0.39) TSHR
SCHEMBL5155590 0.73
SCHEMBL7758299 0.73
SCHEMBL28237871 0.71 TSHR (0.43) TSHR
Hydrochloric Acid SCHEMBL525599 0.71 TSHR (0.43) TSHR
SCHEMBL27634162 0.71 TSHR (0.34) TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1863446-A2 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF LIOTHYRONINE AND METHODS OF MAKING AND USING THE SAME King Pharmaceuticals Research and Development Inc. (US) 2007-12-12 EP disclosed
US-20060246133-A1 Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same CREDIT SUISSE AG 2006-11-02 US disclosed
WO-2006105482-A2 CONTROLLED RELEASE PHARMACEUTICAL COMPOSITIONS OF LIOTHYRONINE AND METHODS OF MAKING AND USING THE SAME KING PHARMACEUTICALS RESEARCH & DEVELOPMENT, INC. (US) 2006-10-05 WO disclosed